BCMA Archives - Medical Conferences

Promising phase 1 results for novel CAR T-cell therapy in MM

Presented By

Dr Binod Dhakal, Medical College of Wisconsin, WI, USA

Trial

Phase 1

Conference

EHA 2024

Type

Peer-reviewed article

12 August 2024 14:17

DREAMM 8: Belantamab mafodotin offers hope for patients with RRMM

Presented By

Prof. Meletious Dimopoulos, University of Athens, Greece

Trial

Phase 3, DREAMM 8

Conference

EHA 2024

Type

Peer-reviewed article

12 August 2024 14:16

Immune therapy of multiple myeloma

Presented By

Prof. Noopur Raje, Massachusetts General Cancer Center, USA

Trial

KarMMA; CARTITUDE-1; UNIVERSAL

Conference

EHA 2021

Type

Peer-reviewed article

5 August 2021 14:49

BCMA-targeted CAR T therapy yields 100% response in relapsed/refractory MM

Presented By

Dr Deepu Madduri, Mount Sinai Medical Center, USA

Trial

Phase 1/2, CARTITUDE-1

Conference

ASH 2019

Type

Peer-reviewed article

5 March 2020 20:29

Anti-BCMA/anti-CD38 in refractory multiple myeloma

Presented By

Prof. Yu Hu, Huazhong University of Science and Technology, China

Conference

ASH 2019

Type

Peer-reviewed article

5 March 2020 16:31

Chimeric antigen receptor T cell therapy in multiple myeloma

Presented By

Prof. Hermann Einsele, University of Würzburg, Germany

Conference

EHA 2019

Type

Peer-reviewed article

9 August 2019 22:34